131 related articles for article (PubMed ID: 20500542)
1. Temporary arrest of basal cell carcinoma formation in a patient with basal cell naevus syndrome (BCNS) since treatment with a gel containing various plant extracts.
Tjeerdsma F; Jonkman MF; Spoo JR
J Eur Acad Dermatol Venereol; 2011 Feb; 25(2):244-5. PubMed ID: 20500542
[No Abstract] [Full Text] [Related]
2. Tazarotene: randomized, double-blind, vehicle-controlled, and open-label concurrent trials for basal cell carcinoma prevention and therapy in patients with basal cell nevus syndrome.
Tang JY; Chiou AS; Mackay-Wiggan JM; Aszterbaum M; Chanana AM; Lee W; Lindgren JA; Raphael MA; Thompson BJ; Bickers DR; Epstein EH
Cancer Prev Res (Phila); 2014 Mar; 7(3):292-9. PubMed ID: 24441673
[TBL] [Abstract][Full Text] [Related]
3. Vismodegib in advanced basal-cell carcinoma.
Henkin RI
N Engl J Med; 2012 Sep; 367(10):970; author reply 970-1. PubMed ID: 22931271
[No Abstract] [Full Text] [Related]
4. Oral hedgehog-pathway inhibitors for basal-cell carcinoma.
Lear JT
N Engl J Med; 2012 Jun; 366(23):2225-6. PubMed ID: 22670909
[No Abstract] [Full Text] [Related]
5. Comparison of daily dosing versus Monday through Friday dosing of vismodegib for locally advanced basal cell carcinoma and basal cell nevus syndrome: A retrospective case series.
Wong C; Poblete-Lopez C; Vidimos A
J Am Acad Dermatol; 2020 Jun; 82(6):1539-1542. PubMed ID: 32092372
[No Abstract] [Full Text] [Related]
6. Resolution of odontogenic keratocysts of the jaw in basal cell nevus syndrome with GDC-0449.
Goldberg LH; Landau JM; Moody MN; Kazakevich N; Holzer AM; Myers A
Arch Dermatol; 2011 Jul; 147(7):839-41. PubMed ID: 21422324
[TBL] [Abstract][Full Text] [Related]
7. Hyposensitivity of basal cell naevus syndrome dermal fibroblasts to ultraviolet A.
Bassukus ID; Schell H; Arai A; Hofmann P
Lancet; 1990 Sep; 336(8718):825. PubMed ID: 1976193
[No Abstract] [Full Text] [Related]
8. Comprehensive treatment of basal cell carcinoma in nevoid basal cell carcinoma syndrome with 5-fluorouracil and salicylic acid.
Yu Y; Zhang G; Fu S
Dermatol Ther; 2022 Dec; 35(12):e15972. PubMed ID: 36346027
[No Abstract] [Full Text] [Related]
9. Nodular basal cell carcinoma in Gorlin's syndrome treated with systemic photodynamic therapy and interstitial optical fiber diffuser laser.
Madan V; Loncaster JA; Allan D; Lear JT; Sheridan L; Leach C; Allan E
J Am Acad Dermatol; 2006 Nov; 55(5 Suppl):S86-9. PubMed ID: 17052541
[TBL] [Abstract][Full Text] [Related]
10. Blue light versus red light for photodynamic therapy of basal cell carcinoma in patients with Gorlin syndrome: A bilaterally controlled comparison study.
Maytin EV; Kaw U; Ilyas M; Mack JA; Hu B
Photodiagnosis Photodyn Ther; 2018 Jun; 22():7-13. PubMed ID: 29471147
[TBL] [Abstract][Full Text] [Related]
11. Death from metastatic basal cell carcinoma: herbal remedy or just unlucky?
Laub DR
J Plast Reconstr Aesthet Surg; 2008 Jul; 61(7):846-8. PubMed ID: 18472318
[No Abstract] [Full Text] [Related]
12. Photodynamic therapy for basal cell carcinoma.
Fargnoli MC; Peris K
Future Oncol; 2015 Nov; 11(22):2991-6. PubMed ID: 26550910
[TBL] [Abstract][Full Text] [Related]
13. Hedgehog Pathway Inhibition for Locally Advanced Periocular Basal Cell Carcinoma and Basal Cell Nevus Syndrome.
Ozgur OK; Yin V; Chou E; Ball S; Kies M; William WN; Migden M; Thuro BA; Esmaeli B
Am J Ophthalmol; 2015 Aug; 160(2):220-227.e2. PubMed ID: 25935097
[TBL] [Abstract][Full Text] [Related]
14. The use of imiquimod 5% cream for the treatment of basal cell carcinoma as observed in Gorlin's syndrome.
Micali G; Lacarrubba F; Nasca MR; De Pasquale R
Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():19-23. PubMed ID: 14616807
[TBL] [Abstract][Full Text] [Related]
15. A 10-year follow-up on the chemopreventive role of photodynamic therapy in a Gorlin syndrome patient.
Thompson A; Mattia A; Green WH; Cognetta AB
Australas J Dermatol; 2022 Nov; 63(4):e378-e379. PubMed ID: 36222440
[No Abstract] [Full Text] [Related]
16. Sunscreen may prevent the development of basal cell carcinoma in individuals with basal cell carcinoma nevus syndrome: A retrospective survey study.
Waldman RA; Grant-Kels JM
J Am Acad Dermatol; 2019 Oct; 81(4):1028-1030. PubMed ID: 30928468
[No Abstract] [Full Text] [Related]
17. The sap from Euphorbia peplus is effective against human nonmelanoma skin cancers.
Ramsay JR; Suhrbier A; Aylward JH; Ogbourne S; Cozzi SJ; Poulsen MG; Baumann KC; Welburn P; Redlich GL; Parsons PG
Br J Dermatol; 2011 Mar; 164(3):633-6. PubMed ID: 21375515
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy using SnET2 for basal cell nevus syndrome: a case report.
Rifkin R; Reed B; Hetzel F; Chen K
Clin Ther; 1997; 19(4):639-41. PubMed ID: 9377609
[TBL] [Abstract][Full Text] [Related]
19. Urticaria after methyl aminolevulinate photodynamic therapy in a patient with nevoid basal cell carcinoma syndrome.
Wolfe CM; Green WH; Hatfield HK; Cognetta AB
J Drugs Dermatol; 2012 Nov; 11(11):1364-5. PubMed ID: 23135091
[TBL] [Abstract][Full Text] [Related]
20. Topical imiquimod treatment of superficial and nodular basal cell carcinomas in patients affected by basal cell nevus syndrome: a preliminary report.
Micali G; De Pasquale R; Caltabiano R; Impallomeni R; Lacarrubba F
J Dermatolog Treat; 2002 Sep; 13(3):123-7. PubMed ID: 12227875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
